Adaptive Biotechnologies Corp — Form 4
Filed July 7, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
Chief Scientific Officer ROBINS HARLAN S (ADPT) sold 386K shares (~$8.5M) on the open market (27% of holdings). Large sale — ~27% of holdings.
Why this rating
Large sale — ~27% of holdings.
See more from July 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.